{"id":"https://openalex.org/W7148808317","doi":"https://doi.org/10.1158/1538-7445.am2026-3742","title":"Abstract 3742: Immune microenvironment rather than genomic alterations drives hyperprogression-related features in 11q13 amplified Chinese esophageal cancer","display_name":"Abstract 3742: Immune microenvironment rather than genomic alterations drives hyperprogression-related features in 11q13 amplified Chinese esophageal cancer","publication_year":2026,"publication_date":"2026-04-03","ids":{"openalex":"https://openalex.org/W7148808317","doi":"https://doi.org/10.1158/1538-7445.am2026-3742"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2026-3742","doi":"https://doi.org/10.1158/1538-7445.am2026-3742","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-3742","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078187065","display_name":"Ling Deng","orcid":"https://orcid.org/0000-0002-3195-3088","observed_orcids":["https://orcid.org/0000-0002-3195-3088"]},"institutions":[{"id":"https://openalex.org/I92039509","display_name":"Guangzhou Medical University","ror":"https://ror.org/00zat6v61","country_code":"CN","type":"education","lineage":["https://openalex.org/I92039509"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ling Deng","raw_affiliation_strings":["Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Qingyuan City, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangzhou Medical University Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Qingyuan City, China","institution_ids":["https://openalex.org/I92039509"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078187065"],"corresponding_institution_ids":["https://openalex.org/I92039509"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"7_Supplement","first_page":"3742","last_page":"3742"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.046300001442432404,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/esophageal-cancer","display_name":"esophageal cancer","score":0.9760000109672546},{"id":"https://openalex.org/keywords/11q13-amplification","display_name":"11q13 amplification","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hyperprogressive-disease","display_name":"hyperprogressive disease","score":0.8510000109672546},{"id":"https://openalex.org/keywords/immune-microenvironment","display_name":"immune microenvironment","score":0.9049999713897705},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.8489999771118164},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.847000002861023},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8740000128746033},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.800000011920929},{"id":"https://openalex.org/keywords/pd-1-cd8-t-cells","display_name":"PD-1+CD8+ T cells","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.781000018119812},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.7070000171661377},{"id":"https://openalex.org/keywords/intratumor-heterogeneity","display_name":"intratumoral heterogeneity","score":0.9850000143051147},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.6759999990463257},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.6069999933242798},{"id":"https://openalex.org/keywords/multiplex-immunofluorescence","display_name":"multiplex immunofluorescence","score":0.7979999780654907}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7421000003814697},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6952000260353088},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6341000199317932},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6074000000953674},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5742999911308289},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.33649998903274536},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.33320000767707825},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.3312999904155731},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31450000405311584},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3125999867916107},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.2994000017642975},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.2971999943256378},{"id":"https://openalex.org/C2776950831","wikidata":"https://www.wikidata.org/wiki/Q15635432","display_name":"Single-cell analysis","level":3,"score":0.2953000068664551},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.2799000144004822},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2775000035762787},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.271699994802475},{"id":"https://openalex.org/C2778236600","wikidata":"https://www.wikidata.org/wiki/Q592324","display_name":"Immunofluorescence","level":3,"score":0.26809999346733093},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26739999651908875},{"id":"https://openalex.org/C196822366","wikidata":"https://www.wikidata.org/wiki/Q270524","display_name":"Parenchyma","level":2,"score":0.26510000228881836},{"id":"https://openalex.org/C2779742542","wikidata":"https://www.wikidata.org/wiki/Q372701","display_name":"Esophageal cancer","level":3,"score":0.25929999351501465},{"id":"https://openalex.org/C90583042","wikidata":"https://www.wikidata.org/wiki/Q1952456","display_name":"Multiplex polymerase chain reaction","level":4,"score":0.2524999976158142},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.2513999938964844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2026-3742","doi":"https://doi.org/10.1158/1538-7445.am2026-3742","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-3742","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Immune":[2,334],"checkpoint":[3],"inhibitors":[4],"(ICIs)":[5],"have":[6,28],"transformed":[7],"the":[8,75,142,158,213,228,308,320,353],"therapeutic":[9,324],"landscape":[10],"of":[11,18,38,77,201,223,311,352],"esophageal":[12,347],"cancer":[13,348],"(ESCA),":[14],"yet":[15],"a":[16,89],"subset":[17],"patients":[19,85,193],"experience":[20],"hyperprogressive":[21],"disease":[22],"(HPD)":[23],"following":[24],"immunotherapy.":[25],"Previous":[26],"studies":[27],"suggested":[29],"that":[30,67,172,250],"genomic":[31,60,97,134,183,255,338],"alterations":[32,135,256,339],"located":[33],"on":[34],"chromosome":[35],"11q13\u2014including":[36],"amplification":[37,54,128,196,265],"CCND1,":[39],"FGF3,":[40],"FGF4,":[41],"and":[42,74,107,125,136,160,207,221,298,318],"FGF19\u2014may":[43],"contribute":[44],"to":[45,50,72,95,117,133,178,289],"HPD.":[46,78],"This":[47],"study":[48],"aimed":[49],"investigate":[51],"whether":[52],"11q13":[53,127,149,195,264,344],"in":[55,163,212,227,260,266,315,343],"ESCA":[56,84,144,267,317],"is":[57,176,279],"associated":[58,246,281],"with":[59,124,131,194,242,247,271,282],"features":[61,245,286,342],"or":[62,169,276],"distinct":[63,283],"immune":[64,120,137,187,238,251,284,312],"microenvironment":[65,121,188,285,313,335],"characteristics":[66],"could":[68],"help":[69],"explain":[70],"resistance":[71,175],"immunotherapy":[73,174],"development":[76],"Methods:":[79],"Tumor":[80],"samples":[81],"from":[82],"341":[83,143],"were":[86,129],"analyzed":[87],"using":[88],"733-gene":[90],"next-generation":[91],"sequencing":[92],"(NGS)":[93],"panel":[94],"characterize":[96],"profiles,":[98],"including":[99,291],"DDR":[100,164,272],"pathway":[101,165],"alterations,":[102,167,274],"tumor":[103,214,229],"mutation":[104],"burden":[105],"(TMB),":[106],"intratumor":[108],"heterogeneity":[109],"(ITH).":[110],"Multiplex":[111],"immunofluorescence":[112],"(mIF)":[113],"was":[114],"also":[115],"performed":[116],"evaluate":[118],"key":[119],"components.":[122],"Patients":[123],"without":[126],"compared":[130],"respect":[132],"cell":[138,296,303],"infiltration.":[139],"Results:":[140],"Among":[141],"patients,":[145],"49.3%":[146],"(168/341)":[147],"exhibited":[148,197],"amplification.":[150],"Genomic":[151],"analysis":[152],"revealed":[153],"no":[154],"significant":[155],"differences":[156],"between":[157],"11q13-amplified":[159,261,316],"non-amplified":[161],"groups":[162],"gene":[166,273],"TMB,":[168,275],"ITH,":[170,277],"suggesting":[171,249],"11q13-associated":[173],"unlikely":[177],"be":[179],"driven":[180],"by":[181],"intrinsic":[182],"instability.":[184],"In":[185],"contrast,":[186],"profiling":[189],"demonstrated":[190],"marked":[191],"differences:":[192],"significantly":[198,218],"reduced":[199,292],"infiltration":[200,220,297],"FOXP3+":[202],"regulatory":[203,294],"T":[204,209,225,295,302],"cells":[205,210,226],"(P=0.005)":[206],"CD3+CD4+FOXP3+":[208],"(P=0.03)":[211],"stroma,":[215],"while":[216],"showing":[217],"increased":[219,299],"density":[222],"CD8+PD-1+":[224,301],"parenchyma":[230],"(P=0.01":[231],"for":[232,235,322,326,356],"density;":[233],"P=0.02":[234],"positivity).":[236],"These":[237,305],"patterns":[239],"are":[240],"consistent":[241],"previously":[243,287],"reported":[244],"HPD,":[248,290],"dysregulation":[252,314],"rather":[253,336],"than":[254,337],"may":[257],"underlie":[258],"hyperprogression":[259],"ESCA.":[262],"Conclusion:":[263],"does":[268],"not":[269],"correlate":[270],"but":[278],"strongly":[280],"linked":[288],"stromal":[293],"parenchymal":[300],"presence.":[304],"findings":[306],"highlight":[307],"clinical":[309],"importance":[310],"underscore":[319],"need":[321],"tailored":[323],"strategies":[325],"this":[327],"molecular":[328],"subgroup.":[329],"Citation":[330],"Format:":[331],"Ling":[332],"Deng.":[333],"drives":[340],"hyperprogression-related":[341],"amplified":[345],"Chinese":[346],"[abstract].":[349],"In:":[350],"Proceedings":[351],"American":[354],"Association":[355],"Cancer":[357,375],"Research":[358],"Annual":[359],"Meeting":[360],"2026;":[361],"Part":[362],"1":[363],"(Regular":[364],"Abstracts);":[365],"2026":[366],"Apr":[367],"17-22;":[368],"San":[369],"Diego,":[370],"CA.":[371],"Philadelphia":[372],"(PA):":[373],"AACR;":[374],"Res":[376],"2026;86(7":[377],"Suppl):Abstract":[378],"nr":[379],"3742.":[380]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2026-04-04T00:00:00"}